Howard J. Lee

Howard J. Lee

Intensive Care Medicine | Sleep Medicine | Pulmonary Medicine

501 Bath Road
#217
Bristol, PA 19007

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer.

Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer.

Journal: The oncologist

Published: July 03, 2024

Telemedicine-based serious illness conversations, healthcare utilization, and end of life care among patients with advanced lung cancer.

Telemedicine-based serious illness conversations, healthcare utilization, and end of life care among patients with advanced lung cancer.

Journal: The oncologist

Published: April 05, 2024

Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort study.

Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort study.

Journal: Journal of geriatric oncology

Published: March 18, 2024

Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer.

Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer.

Journal: JCO oncology practice

Published: November 17, 2022

Communicating the Information Needed for Treatment Decision Making Among Patients With Pancreatic Cancer Receiving Preoperative Therapy.

Communicating the Information Needed for Treatment Decision Making Among Patients With Pancreatic Cancer Receiving Preoperative Therapy.

Journal: JCO oncology practice

Published: October 07, 2021

Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.

Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.

Journal: Current cardiology reports

Published: May 14, 2021

Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study.

Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study.

Journal: International journal of radiation oncology, biology, physics

Published: November 25, 2019

Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy.

Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy.

Journal: The British journal of radiology

Published: August 01, 2019

Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.

Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: September 17, 2018

Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

Journal: Radiation oncology (London, England)

Published: June 27, 2018

Analysis of Gastrointestinal Toxicity in Patients Receiving Proton Beam Therapy for Prostate Cancer: A Single-Institution Experience.

Analysis of Gastrointestinal Toxicity in Patients Receiving Proton Beam Therapy for Prostate Cancer: A Single-Institution Experience.

Journal: Advances in radiation oncology

Published: June 11, 2018

Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer.

Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer.

Journal: Translational lung cancer research

Published: June 08, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026